Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: Alzheimers Dement. 2023 Jan 25;19(7):3055–3064. doi: 10.1002/alz.12930

Table 1:

Participant Characteristics

Characteristic Control (n = 5)* Sleep-Deprived (n=5)*
Age, years
Mean (SD) 48.12 (10.18) 48.02 (10.3)
Sex, M/F 2/3 2/3
Race, C/AA 2/3 2/3
MMSE
Mean (SD) 28.8 (0.84) 28.8 (0.17)
CSF Aβ42/40 at hour 0
Mean (SD) 0.202 (0.076) 0.165 (0.018)
Plasma Aβ42/40 at hour 0
Mean (SD) 0.149 (0.006) 0.137 (0.007)
SSS on Day of Catheter Placement
Mean (SD) 1.6 (0.89) 1.8 (1.30)
Overnight TST (min)
Mean (SD) 410.2 (52.7) 27.9 (27.1)
Overnight SE (%)
Mean (SD) 73.6 (9.8) 5.1 (4.9)

AA = African American; C = Caucasian; F = female; M = male; MMSE = Mini-Mental State Examination; CSF = cerebrospinal fluid; Aβ = amyloid-β; SSS = Stanford Sleepiness Scale; TST = total sleep time; SE = sleep efficiency; SD = standard deviation.

*

5 participants completed both the sleep-deprived and normal sleep groups with interventions 4–6 months apart; all assessments were completed for each intervention group.